Company profile: PureTech Health
1.1 - Company Overview
Company description
- Provider of biopharma therapies and platforms, including KarXT for schizophrenia (xanomeline + trospium), LYT-100 (deuterated pirfenidone) for idiopathic pulmonary fibrosis, LYT-200 (anti-galectin-9) for hematological malignancies and solid tumors, SPT-300 (oral allopregnanolone) for neurological and neuropsychiatric conditions, plus Vedanta's microbiome-based oral therapies and Entrega's hydrogel-enabled oral biologics.
Products and services
- KarXT (combination-therapy): Combines xanomeline with trospium to treat schizophrenia, preserving efficacy while reducing cholinergic side effects associated with existing medications
- LYT-200 (monoclonal antibody): A monoclonal antibody targeting galectin-9 for treating hematological malignancies and solid tumors, created to address both blood and tissue cancer types
- LYT-100 (deuterated small-molecule): A deuterated form of pirfenidone engineered to treat idiopathic pulmonary fibrosis with improved tolerability
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PureTech Health
Moderna
HQ: United States
Website
- Description: Provider of mRNA-based vaccines and therapeutics, including SPIKEVAX (FDA-approved COVID-19 vaccine), mRESVIA (RSV vaccine for older adults), and pipeline candidates mRNA-1283 (next-gen COVID, Phase 3), mRNA-1010 (flu, Phase 3), mRNA-1647 (CMV, Phase 3), and mRNA-4157 (individualized neoantigen cancer therapy, in collaboration with Merck).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Moderna company profile →
Mount Tam Biotech
HQ: United States
Website
- Description: Provider of services to develop, optimize, and bring to market novel pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mount Tam Biotech company profile →
Alumis
HQ: United States
Website
- Description: Provider of precision medicine solutions focused on the discovery, development, and treatment of autoimmune disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alumis company profile →
Forward Pharma
HQ: Denmark
Website
- Description: Provider of biotechnology focused on the immunomodulatory compound dimethyl fumarate and derivatives for pharmaceutical drug applications to treat immune disorders such as multiple sclerosis and psoriasis; founded in 2005 and headquartered in Copenhagen, Denmark.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Forward Pharma company profile →
Talaris Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology engaged in developing innovative cellular therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Talaris Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PureTech Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PureTech Health
2.2 - Growth funds investing in similar companies to PureTech Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PureTech Health
4.2 - Public trading comparable groups for PureTech Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →